VivoSim Labs, INC. (VIVS)
$0.28-$0.01 (-1.79%) TodayExtended Hours
Adam K. SternVivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.
No Form 4 activity for VIVS in the last 90 days.
8 Form 4 filings on record, the earliest from Aug 11, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Douglas Jay Cohen | Grant or award | Common Stock | 15,000 | $0.00 | - | |
| Keith Murphy - Officer | Grant or award | Common Stock | 15,000 | $0.00 | - | |
| Alison Tjosvold Milhous | Grant or award | Common Stock | 15,000 | $0.00 | - | |
| David Gobel | Grant or award | Common Stock | 15,000 | $0.00 | - | |
| Adam K. Stern | Grant or award | Common Stock | 15,000 | $0.00 | - | |
| Amar Akhtar Sethi - Officer | Grant or award | Options (right to buy) | 53,500 | $0.00 | - | |
| David Gobel | Open-market sale | Common Stock | 3,266 | $2.24 | $7K | |
| Tony Serge Lialin - Officer | Grant or award | Options (right to buy) | 40,000 | $0.00 | - |
VivoSim Labs, INC. (VIVS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-01-30. The full record for VIVS runs to 8 Form 4 filings, the earliest from 2025-08-11. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of VIVS were filed in the last 90 days.
No insider sales of VIVS were filed in the last 90 days. 1 sale is on record for this company.
This page tracks VIVS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add VIVS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
